Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bossuyt

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
The Lancet. Gastroenterology & Hepatology|October 30, 2025
Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort studyGeert R D'Haens, Mark Löwenberg, Filip Baert, et al.
Inflammatory Bowel Diseases|March 30, 2021
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel DiseasesClaire Liefferinckx, Jérémie Bottieau, Jean-François Toubeau, et al.
Journal of Crohn'S & Colitis|October 3, 2022
Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn's and Colitis Organisation [ECCO] Position PaperJurij Hanzel, Peter Bossuyt, Valerie Pittet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2015
Safety and Feasibility of Using the Second-Generation Pillcam Colon Capsule to Assess Active Colonic Crohn's DiseaseGeert D'Haens, Mark Löwenberg, Mark A Samaan, et al.
United European Gastroenterology Journal|May 7, 2021
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseasesFerdinando D'Amico, David T Rubin, Paulo Gustavo Kotze, et al.
Inflammatory Bowel Diseases|February 2, 2017
Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel DiseasesSubrata Ghosh, Edouard Louis, Laurent Beaugerie, et al.
Gastroenterology|February 26, 2026
The effect of dose-intensification after secondary loss of response to ustekinumab in Crohn's disease: Results of the REScUE studyPeter Bossuyt, Jean-Francois Rahier, Filip Baert, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's DiseaseErwin Dreesen, Filip Baert, David Laharie, et al.
Journal of Crohn'S & Colitis|November 5, 2013
European evidence based consensus for endoscopy in inflammatory bowel diseaseVito Annese, Marco Daperno, Matthew D Rutter, et al.
Journal of Crohn'S & Colitis|October 4, 2018
Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With VedolizumabAnnick Moens, Karen van Hoeve, Evelien Humblet, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
The Lancet. Gastroenterology & Hepatology|October 30, 2025
Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort studyGeert R D'Haens, Mark Löwenberg, Filip Baert, et al.
Inflammatory Bowel Diseases|March 30, 2021
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel DiseasesClaire Liefferinckx, Jérémie Bottieau, Jean-François Toubeau, et al.
Journal of Crohn'S & Colitis|October 3, 2022
Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn's and Colitis Organisation [ECCO] Position PaperJurij Hanzel, Peter Bossuyt, Valerie Pittet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2015
Safety and Feasibility of Using the Second-Generation Pillcam Colon Capsule to Assess Active Colonic Crohn's DiseaseGeert D'Haens, Mark Löwenberg, Mark A Samaan, et al.
United European Gastroenterology Journal|May 7, 2021
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseasesFerdinando D'Amico, David T Rubin, Paulo Gustavo Kotze, et al.
Inflammatory Bowel Diseases|February 2, 2017
Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel DiseasesSubrata Ghosh, Edouard Louis, Laurent Beaugerie, et al.
Gastroenterology|February 26, 2026
The effect of dose-intensification after secondary loss of response to ustekinumab in Crohn's disease: Results of the REScUE studyPeter Bossuyt, Jean-Francois Rahier, Filip Baert, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's DiseaseErwin Dreesen, Filip Baert, David Laharie, et al.
Journal of Crohn'S & Colitis|November 5, 2013
European evidence based consensus for endoscopy in inflammatory bowel diseaseVito Annese, Marco Daperno, Matthew D Rutter, et al.
Journal of Crohn'S & Colitis|October 4, 2018
Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With VedolizumabAnnick Moens, Karen van Hoeve, Evelien Humblet, et al.
Pageof 14